Characteristics of vaccine hesitancy in England at the community level

In a recent study posted to the medRxiv* preprint server, researchers evaluated the characteristics of coronavirus disease 2019 (COVID-19) vaccine uptake in England at a community level.

Study: Community-level characteristics of COVID-19 vaccine hesitancy in England: A nationwide cross-sectional study. annaevlanova / ShutterstockStudy: Community-level characteristics of COVID-19 vaccine hesitancy in England: A nationwide cross-sectional study. annaevlanova / Shutterstock

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

The COVID-19 vaccination campaign has been implemented globally to immunize populations against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). In England, the National Health Service (NHS) commenced mass vaccinations in December 2020, and over 43 million individuals had been vaccinated with at least one vaccine dose by the end of 2021. Despite the high vaccination rate, vaccine uptake varies among populations, and vaccine inequality remains a public health concern.

According to one study, income disparity was the principal cause of vaccine inequity between high- and middle-income countries. Other research groups have reported that less-educated people from ethnic minorities with low annual income and low awareness of COVID-19-related health risks had higher distrust towards immunization. Consistent with other reports, South Asians and Black people in the United Kingdom (UK) were less likely to vaccinate than the White population.

The study

The current cross-sectional study assessed vaccine uptake in people aged 12 years or above in England. As of January 1, 2022, the authors retrieved cumulative vaccination data corresponding to the middle layer super output areas (MSOA). Vaccine uptake determinants were evaluated at a high geographical resolution by considering covariates associated with COVID-19 mortality in 2020, political views, socio-demographic characteristics, chronic physical and mental health conditions, and vaccine accessibility.

Socio-demographics were profiled by computing the percentage of Black and minority ethnic (BME), index of multiple deprivations (IMD), percentage of people aged 12 – 24 years, and >65 years in each MSOA. Each MSOA was categorized as predominantly urban (PU) or rural (PR) or urban with significant rural (UR). Political opinion was characterized by computing the percentage of those who voted in favor of the 2016 Brexit referendum and the 2019 general election results. A Bayesian hierarchical model was used to assess the relationship of uptake of COVID-19 vaccines and the community-level characteristics.

Posterior mean of vaccine uptake up until 01-01-2022 in each Middle Layer Super Output Area in England (left) and for the most populated cities accounting for a total 11 212 813 population [47] (right).

Posterior mean of vaccine uptake up until 01-01-2022 in each Middle Layer Super Output Area in England (left) and for the most populated cities accounting for a total 11 212 813 population [47] (right).

Results

The national posterior mean of COVID-19 vaccine uptake was estimated at 81.1%, ranging from 37.6 % in Leeds city to 93.9% in Northumberland with lower uptake in city centers. The least compliant regions shared some characteristics – more likely to be deprived and situated in urban places, a high proportion of young residents and non-White ethnic groups, voting for the Labor party, and less likely to experience chronic health conditions. Contrastingly, high vaccine coverage regions were characterized by the older population, increased prevalence of chronic health conditions, and politically favoring the Conservative party.

IMD was the covariate strongly associated with low vaccine uptake. For example, people living in the most deprived places were 0.55 times less likely to be vaccinated than those living in the least disadvantaged regions. In the same line, areas with diverse and high BME populations had 38% lower odds of vaccine uptake than least ethnically-diverse places. Moreover, regions with high proportions of 12 – 24-year-olds had lower odds of vaccine uptake; areas that voted for the Conservative party had high vaccine coverage.

There was insufficient evidence for a link between the proportion of people voting for the Labor party and the Brexit referendum. Areas with a high COVID-19 mortality rate in the pre-vaccination period had higher odds of vaccine uptake; similar was the case in areas with a high prevalence of high blood pressure or asthma, and the vaccine uptake improved with the increase in vaccine accessibility.

Conclusions

The study investigated a range of characteristics at the community level and their role in vaccine uptake. The findings suggested that MSOAs with low uptake of vaccines were the most deprived and ethnically diverse with a high percentage of young people. Vaccine uptake was high across areas with awareness of COVID-19-related health risks and increased accessibility to vaccination centers.

Moreover, areas that voted for the Conservatives had higher vaccine uptake. The national and international COVID-19 policies have changed throughout 2021, increasing public awareness that might have influenced general behavior towards vaccination. A notable limiting factor was the consideration of BME proportions based on the 2011 census assuming that ethnic composition was essentially the same throughout the decade in the MSOAs.

In conclusion, the study reported that despite high national vaccine coverage in a year, multiple inequalities, mainly associated with deprivation and ethnicity, were still persistent. The authors suggested that these sections be engaged through suitable means (scientists and role models from the target communities) to lower vaccine skepticism.

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Journal references:

Article Revisions

  • May 12 2023 - The preprint preliminary research paper that this article was based upon was accepted for publication in a peer-reviewed Scientific Journal. This article was edited accordingly to include a link to the final peer-reviewed paper, now shown in the sources section.
Tarun Sai Lomte

Written by

Tarun Sai Lomte

Tarun is a writer based in Hyderabad, India. He has a Master’s degree in Biotechnology from the University of Hyderabad and is enthusiastic about scientific research. He enjoys reading research papers and literature reviews and is passionate about writing.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Sai Lomte, Tarun. (2023, May 12). Characteristics of vaccine hesitancy in England at the community level. News-Medical. Retrieved on November 22, 2024 from https://www.news-medical.net/news/20220322/Characteristics-of-vaccine-hesitancy-in-England-at-the-community-level.aspx.

  • MLA

    Sai Lomte, Tarun. "Characteristics of vaccine hesitancy in England at the community level". News-Medical. 22 November 2024. <https://www.news-medical.net/news/20220322/Characteristics-of-vaccine-hesitancy-in-England-at-the-community-level.aspx>.

  • Chicago

    Sai Lomte, Tarun. "Characteristics of vaccine hesitancy in England at the community level". News-Medical. https://www.news-medical.net/news/20220322/Characteristics-of-vaccine-hesitancy-in-England-at-the-community-level.aspx. (accessed November 22, 2024).

  • Harvard

    Sai Lomte, Tarun. 2023. Characteristics of vaccine hesitancy in England at the community level. News-Medical, viewed 22 November 2024, https://www.news-medical.net/news/20220322/Characteristics-of-vaccine-hesitancy-in-England-at-the-community-level.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Early RSV vaccination in pregnancy provides best protection for newborns